Detalles de la búsqueda
1.
A phase 2 trial of chemotherapy plus pembrolizumab in patients with advanced non-small cell lung cancer previously treated with a PD-1 or PD-L1 inhibitor: Big Ten Cancer Research Consortium BTCRC-LUN15-029.
Cancer
; 129(2): 264-271, 2023 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36420773
2.
Assessment of adherence and relative dose intensity with oral chemotherapy in oncology clinical trials at an academic medical center.
J Oncol Pharm Pract
; 24(5): 348-353, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28457192
3.
Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial.
Lancet Oncol
; 18(12): 1610-1623, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29129443
4.
Phase I Dose-Escalation Study of Pilaralisib (SAR245408, XL147) in Combination with Paclitaxel and Carboplatin in Patients with Solid Tumors.
Oncologist
; 22(4): 377-e37, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28275119
5.
Bendamustine + rituximab chemoimmunotherapy and maintenance lenalidomide in relapsed, refractory chronic lymphocytic leukaemia and small lymphocytic lymphoma: A Wisconsin Oncology Network Study.
Br J Haematol
; 173(2): 283-91, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26913697
6.
A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung Cancer.
Oncologist
; 21(10): 1163-1164, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27694157
7.
A phase 2 study of weekly temsirolimus and bortezomib for relapsed or refractory B-cell non-Hodgkin lymphoma: A Wisconsin Oncology Network study.
Cancer
; 121(19): 3465-71, 2015 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26079295
8.
A phase I study to determine the maximum tolerated dose and safety of oral LR-103 (1α,24(S)Dihydroxyvitamin D2) in patients with advanced cancer.
J Oncol Pharm Pract
; 21(6): 416-24, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24986793
9.
A phase I study of AT-101 with cisplatin and etoposide in patients with advanced solid tumors with an expanded cohort in extensive-stage small cell lung cancer.
Invest New Drugs
; 32(2): 295-302, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23860642
10.
Vorinostat and bortezomib as third-line therapy in patients with advanced non-small cell lung cancer: a Wisconsin Oncology Network Phase II study.
Invest New Drugs
; 32(1): 195-9, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23728919
11.
Metastasis of primary lung carcinoma to the breast: a systematic review of the literature.
J Surg Res
; 188(2): 419-31, 2014 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24560348
12.
Yttrium 90-ibritumomab tiuxetan plus rituximab maintenance as initial therapy for patients with high-tumor-burden follicular lymphoma: a Wisconsin Oncology Network study.
Clin Adv Hematol Oncol
; 12(8): 509-15, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25356575
13.
Genomic and Immune Landscape Comparison of MET Exon 14 Skipping and MET-Amplified Non-small Cell Lung Cancer.
Clin Lung Cancer
; 2024 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38852006
14.
Combining Dual Checkpoint Immunotherapy with Ablative Radiation to All Sites of Oligometastatic Non-Small Cell Lung Cancer: Toxicity and Efficacy Results of a Phase 1b Trial.
Int J Radiat Oncol Biol Phys
; 118(5): 1481-1489, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38072321
15.
An eHealth system supporting palliative care for patients with non-small cell lung cancer: a randomized trial.
Cancer
; 119(9): 1744-51, 2013 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23355273
16.
A phase I study of sorafenib, oxaliplatin and 2 days of high dose capecitabine in advanced pancreatic and biliary tract cancer: a Wisconsin oncology network study.
Invest New Drugs
; 31(4): 943-8, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23263993
17.
A phase I study of vorinostat in combination with bortezomib in patients with advanced malignancies.
Invest New Drugs
; 31(6): 1539-46, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24114121
18.
Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies.
Invest New Drugs
; 29(2): 316-22, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19997959
19.
Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study.
Lancet Oncol
; 11(10): 962-72, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20851682
20.
A dose escalation, safety, and tolerability study of MN-029 in patients with advanced solid tumors.
Invest New Drugs
; 28(4): 509-15, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19434370